Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
---|
07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
07/13/2011 | CN102124123A Novel nitroreductase enzymatic substrates |
07/12/2011 | US7977334 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity modulator, insulin resistance |
07/12/2011 | CA2498275C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
07/12/2011 | CA2445341C Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof |
07/07/2011 | WO2011080139A1 Amino alcohol derivatives and their therapeutic activities |
07/07/2011 | US20110166181 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
07/06/2011 | EP2341064A1 Benzimidazole compounds and their use as chromatographic ligands |
07/06/2011 | EP1870438B1 Phthalocyanine compound, process for producing the same, and colored composition containing the phthalocyanine compound |
07/06/2011 | EP1611108B1 Method for the production of telmisartan |
07/06/2011 | CN1777577B Antibacterial agents |
07/06/2011 | CN102115461A Method for preparing benzimidazole cationic compound and hydrogen from dihydro benzimidazole compound |
07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
07/05/2011 | US7973066 Pyrrolo[1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
07/05/2011 | CA2446136C Pyruvate derivatives |
06/30/2011 | WO2011079193A2 Preparation of bendamustine and its salts |
06/30/2011 | WO2011077444A1 A new process for the preparation of pure telmisartan |
06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
06/29/2011 | EP2338886A2 Naphthalene derivatives |
06/29/2011 | CN1834090B Benzimidazole compounds, its preparation and uses |
06/28/2011 | US7968727 Synthesis of 4-bromomethyl-2′-formylbiphenyl and 4-bromomethyl-2′-hydroxymethylbiphenyl and its use in preparation of angiotensin II antagonists |
06/28/2011 | US7968578 Indole amide derivatives as EP4 receptor antagonists |
06/28/2011 | US7968576 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
06/28/2011 | US7968567 Compounds for the modulation of PPARγ activity |
06/28/2011 | CA2496241C 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
06/23/2011 | WO2011075634A1 Bicyclic derivatives useful as inhibitors of dpp-1 |
06/23/2011 | US20110152337 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
06/23/2011 | US20110152261 Organic compounds |
06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
06/22/2011 | EP2334652A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
06/22/2011 | EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues |
06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
06/21/2011 | US7964204 Isoxazolines for controlling invertebrate pests |
06/21/2011 | CA2507707C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
06/16/2011 | WO2011071314A2 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms |
06/16/2011 | WO2007011170A9 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
06/16/2011 | US20110144146 Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor |
06/16/2011 | US20110140093 Compounds for use in light-emitting devices |
06/16/2011 | DE102010055499A1 Preparing bendamustine alkyl ester compounds, comprises reacting substituted 2-((2-hydroxy-ethyl)-phenyl-amino)-ethanol compounds with a mixture comprising carbonyl amine compounds and sulfonyl compounds, or diketo compounds |
06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
06/15/2011 | EP2332905A1 BCRP/ABCG3 Inhibitor |
06/15/2011 | EP1937650B1 Heterocyclic compounds |
06/15/2011 | CN102093297A Telmisartan compound and new preparation method thereof |
06/15/2011 | CN102093239A Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids |
06/14/2011 | US7960562 Propane-1,3-dione derivative or salt thereof |
06/14/2011 | US7960561 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
06/14/2011 | US7960398 Potent inhibitors of TNF activity |
06/09/2011 | WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
06/09/2011 | WO2011068560A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
06/09/2011 | US20110137045 Benzimidazole derivatives |
06/09/2011 | US20110136735 Cyclohexane derivatives and uses thereof |
06/09/2011 | CA2781521A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
06/09/2011 | CA2778586A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
06/08/2011 | EP2328875A2 Targeted nitroxide agents |
06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
06/08/2011 | CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
06/08/2011 | CN101514190B Method for preparing heterocyclic compounds of methyl mercapto under ionic liquid catalysis |
06/08/2011 | CN101328152B Piperazidine compound and pyridine compound |
06/08/2011 | CN101203522B Antineoplastic compounds and pharmaceutical compositions thereof |
06/07/2011 | US7956196 the major cause of lower respiratory tract illness during infancy and childhood |
06/07/2011 | US7956195 reacting arylboronic acids with a cycloalkanone, in the presence of a rhodium catalyst or BINAP, to form a substituted arylcycloalkanone, then formin of a hydantoin, alkylation of the hydantoin, resolution, hydrolysis of the hydantoin to the amino acids and esterification of acids; chemical intermediates |
06/07/2011 | US7956071 Imidazole compounds |
06/07/2011 | US7956066 Imidazole compounds |
06/07/2011 | US7956057 Imidazole compounds |
06/07/2011 | US7955816 Design and synthesis of biotinylated probes for N-acyl-ethanolamines |
06/07/2011 | CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
06/02/2011 | US20110129762 Method of increasing hydrophilic property of crystalline carbon using surface modifier and method of preparing platinum catalyst using the same |
06/01/2011 | EP2327690A1 Tricyclic compound |
06/01/2011 | EP2326176A1 Non-amidic linkers with branched termini as cgrp receptor antagonists |
06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
06/01/2011 | CN102082230A Infrared organic electroluminescent device |
06/01/2011 | CN102079729A Compounds with antiparasitic activity and medicaments containing them |
06/01/2011 | CN101209996B Chemical synthesis method for 2-hydroxybenzimadazoles |
05/31/2011 | US7951829 Benzimidazole modulators of VR1 |
05/31/2011 | US7951808 Imidazole compounds |
05/31/2011 | CA2319080C Multivalent antibacterial agents |
05/27/2011 | CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
05/26/2011 | WO2011061935A1 Process for producing 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative and intermediate thereof |
05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
05/26/2011 | US20110123586 Inhibition of quorum sensing-mediated processes in bacteria |
05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
05/25/2011 | EP2323978A1 Amide compound |
05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
05/25/2011 | CN102070535A Preparing method for synthesizing sanmate from calcium cyanamide |
05/25/2011 | CN102070534A Method for preparing telmisartan intermediate |
05/25/2011 | CN101370787B 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
05/24/2011 | US7947709 Non-nucleoside reverse transcriptase inhibitors |
05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
05/19/2011 | WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
05/19/2011 | US20110118219 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
05/19/2011 | US20110114934 New anthracene derivative and an organic electronic device using the same |
05/19/2011 | CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
05/18/2011 | EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3 |
05/18/2011 | EP2322512A1 Alkylated benzimidazolone compounds and self-assembled nanostructures generated therefrom |
05/18/2011 | EP2322511A1 Process for the production of Telmisartan |
05/18/2011 | EP2321282A1 New benzimidazole derivatives |
05/18/2011 | EP2079709B1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |